(TRX) Tanzanian Royalty - Overview
Exchange: NYSE MKT •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA87601A1075
Stock: Gold, Exploration, Development, Production
Total Rating 57
Risk 39
Buy Signal 0.92
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 143% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.28 |
| Alpha | 378.26 |
| Character TTM | |
|---|---|
| Beta | 0.608 |
| Beta Downside | 0.824 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.79% |
| CAGR/Max DD | 0.95 |
Description: TRX Tanzanian Royalty January 19, 2026
TRX Gold Corporation (NYSE MKT: TRX) is a Canadian-incorporated explorer focused on the Buckreef Gold Project in Tanzania, handling exploration, development, and eventual production. The firm, originally Tanzanian Gold Corporation, rebranded in May 2022 and is headquartered in Oakville, Ontario.
According to its latest public update (Q3 2024), Buckreef’s measured and indicated resource stands at roughly 1.1 million ounces of gold at an average grade of 4.5 g/t, supporting a 2025-2026 production target of 80,000–100,000 oz per year with an estimated cash-cost of $850–$950 per ounce. Tanzania’s recent mining-code revisions, which lower royalties to 3 % for projects under 2 million ounces, improve the project’s net-present-value assumptions, while the global gold price hovering around $1,950/oz provides a favorable revenue backdrop.
For a deeper quantitative dive, the ValueRay platform offers a consolidated view of TRX’s financials, peer benchmarks, and risk metrics.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -7.27m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 3.11 > 1.0 |
| NWC/Revenue: 4.12% < 20% (prev -9.85%; Δ 13.97% < -1%) |
| CFO/TA 0.14 > 3% & CFO 25.7m > Net Income -7.27m |
| Net Debt (-6.41m) to EBITDA (13.2m): -0.49 < 3 |
| Current Ratio: 1.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (294.9m) vs 12m ago 0.48% < -2% |
| Gross Margin: 46.50% > 18% (prev 0.43%; Δ 4608 % > 0.5%) |
| Asset Turnover: 54.98% > 50% (prev 42.11%; Δ 12.87% > 0%) |
| Interest Coverage Ratio: 2.75 > 6 (EBITDA TTM 13.2m / Interest Expense TTM 3.45m) |
Altman Z'' -1.60
| A: 0.02 (Total Current Assets 49.7m - Total Current Liabilities 46.0m) / Total Assets 180.4m |
| B: -0.97 (Retained Earnings -174.6m / Total Assets 180.4m) |
| C: 0.06 (EBIT TTM 9.46m / Avg Total Assets 161.9m) |
| D: 0.98 (Book Value of Equity 74.9m / Total Liabilities 76.7m) |
| Altman-Z'' Score: -1.60 = D |
Beneish M -1.97
| DSRI: 2.27 (Receivables 10.8m/3.22m, Revenue 89.0m/60.4m) |
| GMI: 0.92 (GM 46.50% / 42.60%) |
| AQI: 0.89 (AQ_t 0.04 / AQ_t-1 0.04) |
| SGI: 1.47 (Revenue 89.0m / 60.4m) |
| TATA: -0.18 (NI -7.27m - CFO 25.7m) / TA 180.4m) |
| Beneish M-Score: -1.97 (Cap -4..+1) = B |
What is the price of TRX shares?
As of February 08, 2026, the stock is trading at USD 1.59 with a total of 6,281,172 shares traded.
Over the past week, the price has changed by -2.45%, over one month by +82.76%, over three months by +178.95% and over the past year by +387.43%.
Over the past week, the price has changed by -2.45%, over one month by +82.76%, over three months by +178.95% and over the past year by +387.43%.
Is TRX a buy, sell or hold?
Tanzanian Royalty has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy TRX.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TRX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1.6 | -0.6% |
| Analysts Target Price | 1.6 | -0.6% |
| ValueRay Target Price | 1.6 | 1.9% |
TRX Fundamental Data Overview February 07, 2026
P/E Forward = 22.9358
P/S = 6.6143
P/B = 8.6805
Revenue TTM = 89.0m USD
EBIT TTM = 9.46m USD
EBITDA TTM = 13.2m USD
Long Term Debt = 997.0k USD (from longTermDebt, last quarter)
Short Term Debt = 2.44m USD (from shortTermDebt, last quarter)
Debt = 6.35m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -6.41m USD (from netDebt column, last quarter)
Enterprise Value = 457.9m USD (464.3m + Debt 6.35m - CCE 12.8m)
Interest Coverage Ratio = 2.75 (Ebit TTM 9.46m / Interest Expense TTM 3.45m)
EV/FCF = 105.7x (Enterprise Value 457.9m / FCF TTM 4.33m)
FCF Yield = 0.95% (FCF TTM 4.33m / Enterprise Value 457.9m)
FCF Margin = 4.87% (FCF TTM 4.33m / Revenue TTM 89.0m)
Net Margin = -8.17% (Net Income TTM -7.27m / Revenue TTM 89.0m)
Gross Margin = 46.50% ((Revenue TTM 89.0m - Cost of Revenue TTM 47.6m) / Revenue TTM)
Gross Margin QoQ = 56.40% (prev 53.51%)
Tobins Q-Ratio = 2.54 (Enterprise Value 457.9m / Total Assets 180.4m)
Interest Expense / Debt = 4.70% (Interest Expense 298.2k / Debt 6.35m)
Taxrate = 39.74% (7.89m / 19.9m)
NOPAT = 5.70m (EBIT 9.46m * (1 - 39.74%))
Current Ratio = 1.08 (Total Current Assets 49.7m / Total Current Liabilities 46.0m)
Debt / Equity = 0.08 (Debt 6.35m / totalStockholderEquity, last quarter 74.9m)
Debt / EBITDA = -0.49 (Net Debt -6.41m / EBITDA 13.2m)
Debt / FCF = -1.48 (Net Debt -6.41m / FCF TTM 4.33m)
Total Stockholder Equity = 71.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.49% (Net Income -7.27m / Total Assets 180.4m)
RoE = -10.17% (Net Income TTM -7.27m / Total Stockholder Equity 71.5m)
RoCE = 13.06% (EBIT 9.46m / Capital Employed (Equity 71.5m + L.T.Debt 997.0k))
RoIC = 10.15% (NOPAT 5.70m / Invested Capital 56.2m)
WACC = 8.09% (E(464.3m)/V(470.7m) * Re(8.16%) + D(6.35m)/V(470.7m) * Rd(4.70%) * (1-Tc(0.40)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.67%
[DCF Debug] Terminal Value 69.82% ; FCFF base≈4.33m ; Y1≈2.84m ; Y5≈1.30m
Fair Price DCF = 0.11 (EV 25.0m - Net Debt -6.41m = Equity 31.4m / Shares 288.3m; r=8.09% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 28.58 | EPS CAGR: 46.86% | SUE: -1.79 | # QB: 0
Revenue Correlation: 83.42 | Revenue CAGR: 75.40% | SUE: 1.00 | # QB: 2
EPS next Quarter (2026-05-31): EPS=0.02 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-08-31): EPS=0.07 | Chg30d=-0.008 | Revisions Net=-1 | Growth EPS=+216.6% | Growth Revenue=+108.6%
EPS next Year (2027-08-31): EPS=0.20 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+175.9% | Growth Revenue=+32.1%
P/S = 6.6143
P/B = 8.6805
Revenue TTM = 89.0m USD
EBIT TTM = 9.46m USD
EBITDA TTM = 13.2m USD
Long Term Debt = 997.0k USD (from longTermDebt, last quarter)
Short Term Debt = 2.44m USD (from shortTermDebt, last quarter)
Debt = 6.35m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -6.41m USD (from netDebt column, last quarter)
Enterprise Value = 457.9m USD (464.3m + Debt 6.35m - CCE 12.8m)
Interest Coverage Ratio = 2.75 (Ebit TTM 9.46m / Interest Expense TTM 3.45m)
EV/FCF = 105.7x (Enterprise Value 457.9m / FCF TTM 4.33m)
FCF Yield = 0.95% (FCF TTM 4.33m / Enterprise Value 457.9m)
FCF Margin = 4.87% (FCF TTM 4.33m / Revenue TTM 89.0m)
Net Margin = -8.17% (Net Income TTM -7.27m / Revenue TTM 89.0m)
Gross Margin = 46.50% ((Revenue TTM 89.0m - Cost of Revenue TTM 47.6m) / Revenue TTM)
Gross Margin QoQ = 56.40% (prev 53.51%)
Tobins Q-Ratio = 2.54 (Enterprise Value 457.9m / Total Assets 180.4m)
Interest Expense / Debt = 4.70% (Interest Expense 298.2k / Debt 6.35m)
Taxrate = 39.74% (7.89m / 19.9m)
NOPAT = 5.70m (EBIT 9.46m * (1 - 39.74%))
Current Ratio = 1.08 (Total Current Assets 49.7m / Total Current Liabilities 46.0m)
Debt / Equity = 0.08 (Debt 6.35m / totalStockholderEquity, last quarter 74.9m)
Debt / EBITDA = -0.49 (Net Debt -6.41m / EBITDA 13.2m)
Debt / FCF = -1.48 (Net Debt -6.41m / FCF TTM 4.33m)
Total Stockholder Equity = 71.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.49% (Net Income -7.27m / Total Assets 180.4m)
RoE = -10.17% (Net Income TTM -7.27m / Total Stockholder Equity 71.5m)
RoCE = 13.06% (EBIT 9.46m / Capital Employed (Equity 71.5m + L.T.Debt 997.0k))
RoIC = 10.15% (NOPAT 5.70m / Invested Capital 56.2m)
WACC = 8.09% (E(464.3m)/V(470.7m) * Re(8.16%) + D(6.35m)/V(470.7m) * Rd(4.70%) * (1-Tc(0.40)))
Discount Rate = 8.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.67%
[DCF Debug] Terminal Value 69.82% ; FCFF base≈4.33m ; Y1≈2.84m ; Y5≈1.30m
Fair Price DCF = 0.11 (EV 25.0m - Net Debt -6.41m = Equity 31.4m / Shares 288.3m; r=8.09% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 28.58 | EPS CAGR: 46.86% | SUE: -1.79 | # QB: 0
Revenue Correlation: 83.42 | Revenue CAGR: 75.40% | SUE: 1.00 | # QB: 2
EPS next Quarter (2026-05-31): EPS=0.02 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-08-31): EPS=0.07 | Chg30d=-0.008 | Revisions Net=-1 | Growth EPS=+216.6% | Growth Revenue=+108.6%
EPS next Year (2027-08-31): EPS=0.20 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+175.9% | Growth Revenue=+32.1%